PDF icon Download PDF
Dtsch Med Wochenschr 2011; 136(33): 1677
DOI: 10.1055/s-0031-1281576
Pro & Contra | Commentary
Rheumatologie
© Georg Thieme Verlag KG Stuttgart · New York

Parenterale Goldtherapie bei rheumatoider Arthritis – contra

Against parenteral gold therapy in rheumatoid arthritisH. Kellner1
  • 1Schwerpunktpraxis für Rheumatologie und Gastroenterologie und Ärztlicher Leiter Rheuma-Abteilung, Krankenhaus Neuwittelsbach
Further Information

Publication History

Publication Date:
10 August 2011 (online)

Also available ateRef
   Permissions and Reprints
Preview

Schlüsselwörter

rheumatoide Arthritis - Goldtherapie

Keywords

rheumatoid arthritis - gold therapy

Literatur

  • 1 Blumenauer  B. et al . Quality of life in patients with rheumatoid arthritis: which drugs might make a difference?.  Pharmacoeconomics. 2003;  21 927-940
    Search in Google Scholar
  • 2 Fraenkel L. et al . Patient preferences for treatment of rheumatoid arthritis.  Ann Rheum Dis. 2004;  63 1372-1378
    Search in Google Scholar
  • 3 Gaujoux-Viala C. et al . Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis.  Ann Rheum Dis. 2010;  69 1004-1009
    Search in Google Scholar
  • 4 Hurst  S. et al . Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.  J Rheumatol. 2002;  29 1639-1645
    Search in Google Scholar
  • 5 Papadopoulos  N G. et al . Disease modifying antirheumatic drugs in early rheumatoid arthritis: a longterm observational study.  J Rheumatol. 2002;  29 261-266
    Search in Google Scholar

Prof. Dr. Herbert Kellner

Schwerpunktpraxis für Rheumatologie und Gastroenterologie
und Ärztlicher Leiter der Rheuma-Abteilung
Krankenhaus Neuwittelsbach

Romanstr. 9

80639 München

Phone: 089/13959-100

Fax: 089/13959-102